Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 15 July 2018 155:316-336 - Subject
- Language
- ISSN
- 0223-5234